SCHEMBL5705254

SCHEMBL5705254

O=C1Nc2cccc(N3CCN(C(=O)O)CC3)c2CO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.42
DRD3 P35462 2/20 0.42
DRD4 P21917 1/20 0.42
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
CYP2C19 P33261 3/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
HTR1A P08908 2/20 0.36
HTT P42858 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALOX15 P16050 1/20 0.35
AVPR1A P37288 1/20 0.34
SCN5A Q14524 2/20 0.34
SCN9A Q15858 2/20 0.34
SCN1A P35498 1/20 0.34
AKR1C3 P42330 2/20 0.34
RBP4 P02753 1/20 0.34
HTR1D P28221 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4615625 0.83 BACE1 (0.44) ALDH1A1LMNAMAPK1
SCHEMBL4615489 0.71 HTR6 (0.45) DRD2DRD3DRD4KMT2AALDH1A1
SCHEMBL1134900 0.70 DRD2 (0.47) DRD2MEN1KMT2ACYP2C19ALDH1A1
SCHEMBL20597396 0.70 PARP1 (0.38) MEN1KMT2AALDH1A1ALOX15HSD17B10
SCHEMBL1134913 0.68 RBP4 (0.39) DRD2DRD3MEN1KMT2AALDH1A1
SCHEMBL11087705 0.68 KDM4E (0.49) MEN1KMT2ACYP2C19ALDH1A1CYP1A2
SCHEMBL3604854 0.68 CYP11B1 (0.36) ALDH1A1
SCHEMBL27237932 0.68 KDM4E (0.38) MEN1KMT2ACYP2C19ALDH1A1CYP1A2
SCHEMBL1134862 0.68 ALDH1A1 (0.39) DRD2DRD3DRD4MEN1KMT2A
SCHEMBL11193614 0.68 SCN1A (0.54) DRD2DRD3DRD4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708713-A1 1-BENZYL-5-PIPERAZIN-1-YL-3,4 DIHYDRO-1H-QUINAZOLIN-2-ONE DERIVATIVES AND THE RESPECTIVE 1H-BENZO(1,2,6)THIADIAZINE-2,2-DIOXIDE AND 1,4-DIHYDRO-BENZO(D)(1,3)OXAZIN-2-ONE DERIVATIVES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT) FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM F. Hoffman-la Roche AG (CH) 2006-10-11 EP disclosed
WO-2005067933-A1 1-BENZYL-5-PIPERAZIN-1-YL-3,4 DIHYDRO-1H-QUINAZOLIN-2-ONE DERIVATIVES AND THE RESPECTIVE 1H-BENZO(1,2,6)THIADIAZINE-2,2-DIOXIDE AND 1,4-DIHYDRO-BENZO(D) (1,3)OXAZIN-2-ONE DERIVATIVES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT) FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM F. HOFFMANN-LA ROCHE AG (CH) 2005-07-28 WO disclosed